Jyoti Malhotra (@jyotimalhotramd) 's Twitter Profile
Jyoti Malhotra

@jyotimalhotramd

Thoracic & Phase I medical oncologist, @cityofhope, Interested in novel immunotherapies & drug conjugates to target IO resistance, #viewsmyown

ID: 1729112810

calendar_today04-09-2013 15:35:06

182 Tweet

637 Followers

530 Following

Byung-June Park (@onco_park) 's Twitter Profile Photo

In EGFR-mutant NSCLC, drug-tolerant persister cells (DTPCs) that emerge following osimertinib treatment often exhibit epithelial-to-mesenchymal transition (EMT) and increased expression of TROP2 (Baldacci et al., WCLC 2024, Abstract #MA07.06). Supporting this, preclinical data

In EGFR-mutant NSCLC, drug-tolerant persister cells (DTPCs) that emerge following osimertinib treatment often exhibit epithelial-to-mesenchymal transition (EMT) and increased expression of TROP2 (Baldacci et al., WCLC 2024, Abstract #MA07.06). Supporting this, preclinical data
Jill Feldman (@jillfeldman4) 's Twitter Profile Photo

Science has never brought me to tears until today. This poster was presented at #AACR25. The study used a cell line based on paired molecular profiling of biopsies derived from my dear friend Ivy Elkins cancer. Ivy's voice helped shape research, and now her cells are helping

Science has never brought me to tears until today. This poster was presented at #AACR25. The study used a cell line based on paired molecular profiling of biopsies derived from my dear friend <a href="/ivybelkins/">Ivy Elkins</a> cancer. 

Ivy's voice helped shape research, and now her cells are helping
Cancer Research Communications (@crc_aacr) 's Twitter Profile Photo

Recently published: Safety and efficacy of a selective inhibitor of cyclin-dependent kinase 9 (KB-0742) in patients with recurrent or metastatic #adenoidcysticcarcinoma, by Glenn J. Hanna et al. doi.org/10.1158/2767-9… Glenn J. Hanna, M.D. Dana-Farber Jyoti Malhotra #CDK9 #OpenAccess

Recently published:
Safety and efficacy of a selective inhibitor of cyclin-dependent kinase 9 (KB-0742) in patients with recurrent or metastatic #adenoidcysticcarcinoma, by Glenn J. Hanna et al. doi.org/10.1158/2767-9…
<a href="/HeadNeckMD/">Glenn J. Hanna, M.D.</a> <a href="/DanaFarber/">Dana-Farber</a> <a href="/JyotiMalhotraMD/">Jyoti Malhotra</a> #CDK9 #OpenAccess
Julie Gralow (@jrgralow) 's Twitter Profile Photo

If you're an ASCO member, you can join our volunteer-led Communities of Practice. CoPs provide opportunity to build community, fellowship, & network around a special interest area or topic. Many will hold meetings during #ASCO25. Here's the schedule: asco.org/annual-meeting…

City of Hope (@cityofhope) 's Twitter Profile Photo

#ASCO25: The City of Hope booth is open! Stop by to experience our lab-inspired mixology station serving up unique refreshments. Come for the drinks, stay to connect with our team! Sumanta K. Pal, MD, FASCO

#ASCO25: The <a href="/cityofhope/">City of Hope</a> booth is open! Stop by to experience our lab-inspired mixology station serving up unique refreshments.

Come for the drinks, stay to connect with our team! <a href="/montypal/">Sumanta K. Pal, MD, FASCO</a>
City of Hope (@cityofhope) 's Twitter Profile Photo

We’re excited for another day at #ASCO25! From groundbreaking research to inspiring conversations, there’s so much to explore and learn. If you’re attending, come say hello! City of Hope is at Booth No. 36082 and we’d love to connect.

Arya Amini (@draryaamini) 's Twitter Profile Photo

Nice work by William Gombrich, a star medical student and our resident Nicholas Eustace summarizing the role of RT in oligoprogressive NSCLC #radonc Terry Williams Dr. Ravi Salgia Jyoti Malhotra Percy Lee MD mdpi.com/2072-6694/17/7…

GO2 for Lung Cancer (@go2forlungcancr) 's Twitter Profile Photo

A #SmallCellLungCancer (SCLC) diagnosis can feel overwhelming, but no one has to face it alone. 🩵 Our HelpLine is here to support you. 📞 1-800-298-2436 📧 [email protected] 🔗 More details: tinyurl.com/ye5pv78n We’ll help you find answers, resources, and hope.

A #SmallCellLungCancer (SCLC) diagnosis can feel overwhelming, but no one has to face it alone. 

🩵 Our HelpLine is here to support you. 
📞 1-800-298-2436 
📧 support@go2.org 
🔗 More details: tinyurl.com/ye5pv78n  

We’ll help you find answers, resources, and hope.
Sumanta K. Pal, MD, FASCO (@montypal) 's Twitter Profile Photo

Had the best meeting with Matthew Lee, a brilliant #lungcancer specialist who joined us about 6 mos ago. Was fun to hear about his ongoing projects w Balazs Halmos Montefiore Health System (thank u for training him so well!) & projects he is kicking off w Jyoti Malhotra Dr. Ravi Salgia

Had the best meeting with <a href="/matt_cw_lee/">Matthew Lee</a>, a brilliant #lungcancer specialist who joined us about 6 mos ago. Was fun to hear about his ongoing projects w <a href="/BalazsHalmosMD/">Balazs Halmos</a> <a href="/MontefioreNYC/">Montefiore Health System</a> (thank u for training him so well!) &amp; projects he is kicking off w <a href="/JyotiMalhotraMD/">Jyoti Malhotra</a> <a href="/DrRaviSalgia/">Dr. Ravi Salgia</a>